Source 1primary paper2025MED
Toolkit/peptide-guided radionuclides
peptide-guided radionuclides
Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Additionally, we summarize their application in ... peptide-guided radionuclides ...
Usefulness & Problems
Why this is useful
Peptide-guided radionuclides are presented as a peptide application area in cancer diagnosis and therapy. The abstract indicates that the review summarizes their mechanistic principles and clinical evidence.; peptide-guided cancer diagnosis or therapy using radionuclide constructs
Source:
Peptide-guided radionuclides are presented as a peptide application area in cancer diagnosis and therapy. The abstract indicates that the review summarizes their mechanistic principles and clinical evidence.
Source:
peptide-guided cancer diagnosis or therapy using radionuclide constructs
Problem solved
They use peptide guidance to support precision oncology applications involving radionuclides. The review frames this within efforts to improve precision and reduce toxicity.; applies peptide specificity to radionuclide-based oncology modalities
Source:
They use peptide guidance to support precision oncology applications involving radionuclides. The review frames this within efforts to improve precision and reduce toxicity.
Source:
applies peptide specificity to radionuclide-based oncology modalities
Problem links
applies peptide specificity to radionuclide-based oncology modalities
LiteratureThey use peptide guidance to support precision oncology applications involving radionuclides. The review frames this within efforts to improve precision and reduce toxicity.
Source:
They use peptide guidance to support precision oncology applications involving radionuclides. The review frames this within efforts to improve precision and reduce toxicity.
Taxonomy & Function
Primary hierarchy
Mechanism Branch
Architecture: A reusable architecture pattern for arranging parts into an engineered system.
Mechanisms
targeting ligand-mediated guidanceTechniques
Structural CharacterizationTarget processes
No target processes tagged yet.
Input: Chemical
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: actuator
The provided text supports that these approaches require peptide-guided radionuclide constructs. It does not provide radionuclide identities, labeling chemistry, or imaging/therapy protocols.; requires peptide-guided radionuclide construct design
The abstract does not state that peptide-guided radionuclides resolve all translational barriers. It notes that major barriers to clinical use remain under discussion.; specific clinical or technical constraints are not detailed in the abstract
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
The review covers therapeutic peptides as targeting ligands, active agents, peptide-drug conjugates, peptide-guided radionuclides, and cancer vaccines.
Firstly, we outline the main functional classes of therapeutic peptides, covering their use as targeting ligands and their roles as active agents ... Additionally, we summarize their application in peptide-drug conjugates (PDCs), peptide-guided radionuclides, and cancer vaccines ...
A single peptide can serve as a targeting ligand, cell-penetrating motif, therapeutic effector, or structural component of peptide-drug conjugates, nanoparticle systems, and radionuclide constructs.
The same peptide can function as a targeting ligand, a cell-penetrating motif, a therapeutic effector, or a structural component of peptide-drug conjugates (PDCs), nanoparticle (NP) systems, and radionuclide constructs.
Approval Evidence
1 source2 linked approval claimsfirst-pass slug peptide-guided-radionuclides
Additionally, we summarize their application in ... peptide-guided radionuclides ...
Source:
application scopesupports
The review covers therapeutic peptides as targeting ligands, active agents, peptide-drug conjugates, peptide-guided radionuclides, and cancer vaccines.
Firstly, we outline the main functional classes of therapeutic peptides, covering their use as targeting ligands and their roles as active agents ... Additionally, we summarize their application in peptide-drug conjugates (PDCs), peptide-guided radionuclides, and cancer vaccines ...
Source:
functional convergencesupports
A single peptide can serve as a targeting ligand, cell-penetrating motif, therapeutic effector, or structural component of peptide-drug conjugates, nanoparticle systems, and radionuclide constructs.
The same peptide can function as a targeting ligand, a cell-penetrating motif, a therapeutic effector, or a structural component of peptide-drug conjugates (PDCs), nanoparticle (NP) systems, and radionuclide constructs.
Source:
Comparisons
Source-stated alternatives
Other peptide modalities discussed in the same abstract include peptide-drug conjugates, nanoparticle systems, active therapeutic peptides, and cancer vaccines.
Source:
Other peptide modalities discussed in the same abstract include peptide-drug conjugates, nanoparticle systems, active therapeutic peptides, and cancer vaccines.
Source-backed strengths
integrates peptide targeting with radionuclide applications in oncology
Source:
integrates peptide targeting with radionuclide applications in oncology
Compared with peptide-based cancer vaccines
Other peptide modalities discussed in the same abstract include peptide-drug conjugates, nanoparticle systems, active therapeutic peptides, and cancer vaccines.
Shared frame: source-stated alternative in extracted literature
Strengths here: integrates peptide targeting with radionuclide applications in oncology.
Relative tradeoffs: specific clinical or technical constraints are not detailed in the abstract.
Source:
Other peptide modalities discussed in the same abstract include peptide-drug conjugates, nanoparticle systems, active therapeutic peptides, and cancer vaccines.
Compared with peptide-drug conjugates
Other peptide modalities discussed in the same abstract include peptide-drug conjugates, nanoparticle systems, active therapeutic peptides, and cancer vaccines.
Shared frame: source-stated alternative in extracted literature
Strengths here: integrates peptide targeting with radionuclide applications in oncology.
Relative tradeoffs: specific clinical or technical constraints are not detailed in the abstract.
Source:
Other peptide modalities discussed in the same abstract include peptide-drug conjugates, nanoparticle systems, active therapeutic peptides, and cancer vaccines.
Ranked Citations
- 1.